Documents for Download
Registry for long-term follow-up of CML patients who discontinued Imatinib after Complete Cytogenetic Response
![application/pdf](/++resource++zms_/img/mime_type.application_pdf.gif)
for the registry on patients who discontinued imatinib after CCR
![application/pdf](/++resource++zms_/img/mime_type.application_pdf.gif)
(Baseline) time of diagnosis
![application/pdf](/++resource++zms_/img/mime_type.application_pdf.gif)
(Discontinuation of Imatinib) to be filled out at time of 1st discontinuation of Imatinib and every 3 months thereafter
(Discontinuation of Imatinib) to be filled out at time of 1st discontinuation of Imatinib and every 3 months thereafter
(Discontinuation of Imatinib) to be filled out at time of 1st discontinuation of Imatinib and every 3 months thereafter
![application/pdf](/++resource++zms_/img/mime_type.application_pdf.gif)
(Restart of Imatinib) (to be filled out at time of 1st restart of Imatinib and every 3 months thereafter)
![application/pdf](/++resource++zms_/img/mime_type.application_pdf.gif)
(Therapeutic responses before the 1st disc. of I.) to be filled out every 3 months after diagnosis, but only as long as Imatinib was administered, otherwise refer to the 2nd Form